Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-26-461091·Longitude Capital Partners V, LLC
Schedule 13D ownership disclosure
VeraDermics, Inc.
Common Stock, $0.00001 par value per share · CUSIP: 922967104
Event date: 2026-11-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Longitude Capital Partners V, LLCReported CIK 0002018312
Shares: 2,350,399 · Class: 5.6%
- Longitude Venture Partners V, L.P.Reported CIK 0001935964
Shares: 2,350,399 · Class: 5.6%
- Longitude 103.8 East Partners, LLCReported CIK 0002094273
Shares: 1,803,474 · Class: 4.3%
- Longitude 103.8 East, L.P.Reported CIK 0002094269
Shares: 1,803,474 · Class: 4.3%
- Patrick G. EnrightReported CIK 0001253886
Shares: 4,153,873 · Class: 9.8%
- Juliet Tammenoms BakkerReported CIK 0001431159
Shares: 4,153,873 · Class: 9.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-461091
- Form type
- SCHEDULE 13D/A
- Filer
- Longitude Capital Partners V, LLC
- CIK
- CIK 2018312
- Filed
- Nov 13, 2026
- Reporting period
- Nov 11, 2026
- Description
- Schedule 13D beneficial ownership